Published on in Vol 9 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/45747, first published
.
![Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study](https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 480w,https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 960w,https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 1920w,https://asset.jmir.pub/assets/c17e73adb111d556a601098710ff010e.png 2500w)
Journals
- Huang K. The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies. JMIR Public Health and Surveillance 2024;10:e51372 View
- Wang L, Liu S, Jiang S, Li C, Lu L, Fang Y, Li S. Authors’ Reply: “The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies”. JMIR Public Health and Surveillance 2024;10:e54756 View